PL BioScience GmbH | WebDisclosure

Basculer en Français

11141	Companies
245433	Keywords
173480	Articles
132409	Press releases

Home
Companies
PL BioScience GmbH

PRESS RELEASE

published on 06/11/2025 at 10:00, 1 year 3 months ago

PL BioScience Strengthens Management Team with Appointment of Oliver Dick as Chief Technology Officer
PL BioScience strengthens management team with appointment of Oliver Dick as Chief Technology Officer. Oliver Dick brings 30 years of expertise in life science, diagnostic, and biopharma operations

Chief Technology Officer Biopharmaceutical Life Science PL BioScience Oliver Dick
BRIEF

published on 05/19/2025 at 15:05, 1 year 4 months ago

PL BioScience et DewCell s'associent pour développer des plaquettes humaines artificielles

Plaquettes Artificielles Milieux De Culture Cellulaire Développement HPL Solutions Sans Animaux Collaboration Biotechnologique
BRIEF

published on 05/19/2025 at 15:05, 1 year 4 months ago

PL BioScience and DewCell Partner on Artificial Human Platelets

Biotech Collaboration Artificial Platelets Cell Culture Media HPL Development Animal-free Solutions
PRESS RELEASE

published on 05/19/2025 at 15:00, 1 year 4 months ago

PL BioScience and DewCell sign LOI to Jointly Develop Artificial Human Platelets for Scalable, Animal-Free Cell Culture Media
PL BioScience and DewCell sign LOI to jointly develop artificial human platelets for scalable, animal-free cell culture media. The collaboration aims to meet demand driven by regulatory trends in cell- and gene therapy development

PL BioScience Cell Culture Media DewCell Artificial Human Platelets Regulatory Trends
BRIEF

published on 05/08/2025 at 14:05, 1 year 4 months ago

PL BioScience dévoile le premier lysat plaquettaire humain artificiel au monde

Médecine Régénérative Produits Biopharmaceutiques Culture Cellulaire PL BioScience HPL Artificiel
BRIEF

published on 05/08/2025 at 14:05, 1 year 4 months ago

PL BioScience Unveils World's First Artificial Human Platelet Lysate

Regenerative Medicine Biopharmaceuticals Cell Culture PL BioScience Artificial HPL
PRESS RELEASE

published on 05/08/2025 at 14:00, 1 year 4 months ago

PL BioScience Raises the Bar in Cell Culture Technology with First Artificial Human Platelet Lysate Worldwide
PL BioScience GmbH introduces first artificial Human Platelet Lysate (HPL) worldwide, revolutionizing cell culture technology for biopharmaceutical applications

Biopharmaceutical Human Platelet Lysate PL BioScience Artificial Cell Culture Technology
BRIEF

published on 04/30/2025 at 12:05, 1 year 5 months ago

PL BioScience Unveils Unique Gamma-irradiated Human Platelet Lysate

Regenerative Medicine Cell Therapy Human Platelet Lysate Gamma-Irradiation Xeno-Free Supplement
BRIEF

published on 04/30/2025 at 12:05, 1 year 5 months ago

PL BioScience dévoile un lysat plaquettaire humain unique irradié aux rayons gamma

Médecine Régénérative Thérapie Cellulaire Lysat Plaquettaire Humain Irradiation Gamma Supplément Sans Xénobiotiques
PRESS RELEASE

published on 04/30/2025 at 12:00, 1 year 5 months ago

PL BioScience Launches World’s Only Patented Gamma-irradiated Human Platelet Lysate
PL BioScience launches ELAREM™ Ultimate-FD PLUS, the only gamma-irradiated, GMP-grade Human Platelet Lysate in Europe. The product offers a safer, sustainable, virus-inactivated, and animal-free alternative for cell manufacturing applications

GMP-grade Human Platelet Lysate PL BioScience ELAREM Ultimate-FD PLUS Gamma-irradiated

Accesswire

Published on 10/07/2026 at 01:45, 1 hour 53 minutes ago

Final Tunkillia Assays Among the Best Infill Results To-Date, with Broad, High-Grade Intersections Throughout 'Starter Pit' Outlines
Published on 10/07/2026 at 01:30, 2 hours 8 minutes ago

ECC Ventures 4 Corp. Announces Resumption of Trading
Published on 10/07/2026 at 01:05, 2 hours 33 minutes ago

Alaska Energy Metals Reports on At-The-Market Equity Financing Program
Published on 10/06/2026 at 23:45, 3 hours 53 minutes ago

Gamma Resources Closes $1,750,000 Private Placement
Published on 10/06/2026 at 23:32, 4 hours 6 minutes ago

Battery X Metals Announces Closing of First Tranche of Private Placement Financing

View all ACCESSWIRE

EQS Group

Published on 10/06/2026 at 19:05, 8 hours 33 minutes ago

Cambridge Heartwear Awarded £184 Million NHS Tender for World's First Medical-Grade, Wirelessly Charged, Reusable ECG Wearable
Published on 10/06/2026 at 18:30, 9 hours 8 minutes ago

Avolta’s Hudson secures new 20-year duty-free contract at Seattle-Tacoma International
Published on 10/06/2026 at 18:05, 9 hours 33 minutes ago

Lepermislibre: INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL SOCIAL
Published on 10/06/2026 at 18:00, 9 hours 38 minutes ago

ARVERNE GROUP: Nombre total de droits de vote et d’actions composant le capital social au 30 septembre 2026
Published on 10/06/2026 at 18:00, 9 hours 38 minutes ago

ARVERNE GROUP: Total number of shares and voting rights in the share capital as of September 30, 2026

Les Echos

Published on 10/06/2026 at 19:15, 8 hours 23 minutes ago

Air Liquide has successfully issued a 2 billion euros multi-tranche bond
Published on 10/06/2026 at 19:15, 8 hours 23 minutes ago

Air Liquide a réalisé avec succès une émission obligataire multi-tranches de 2 milliards d’euros
Published on 10/06/2026 at 18:39, 8 hours 59 minutes ago

Capital et droits de vote au 30 septembre 2026
Published on 10/06/2026 at 18:39, 8 hours 59 minutes ago

Total number of voting rights and shares making up the share capital at September 30, 2026
Published on 10/06/2026 at 18:15, 9 hours 23 minutes ago

AXA: Information relating to the number of voting rights and shares making up the share capital on 30/09/2026

View all LES ECHOS COMFI WIRE